Sona Nanotech (XCNQ:SONA) Debt-to-Equity : 0.24 (As of Jan. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Debt-to-Equity?

Sona Nanotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2025 was C$0.00 Mil. Sona Nanotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2025 was C$0.41 Mil. Sona Nanotech's Total Stockholders Equity for the quarter that ended in Jan. 2025 was C$1.69 Mil. Sona Nanotech's debt to equity for the quarter that ended in Jan. 2025 was 0.24.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Sona Nanotech's Debt-to-Equity or its related term are showing as below:

XCNQ:SONA' s Debt-to-Equity Range Over the Past 10 Years
Min: -5.54 Med: 0.12 Max: 5.49
Current: 0.24

During the past 13 years, the highest Debt-to-Equity Ratio of Sona Nanotech was 5.49. The lowest was -5.54. And the median was 0.12.

XCNQ:SONA's Debt-to-Equity is ranked worse than
51.04% of 192 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs XCNQ:SONA: 0.24

Sona Nanotech Debt-to-Equity Historical Data

The historical data trend for Sona Nanotech's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Debt-to-Equity Chart

Sona Nanotech Annual Data

Trend

Oct14

Oct15

Oct16

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Debt-to-Equity

Get a 7-Day Free Trial

-0.43

-1.09

-1.20

0.45

0.16

Sona Nanotech Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Debt-to-Equity	Get a 7-Day Free Trial															0.45	1.15	-5.02	0.16	0.24

Competitive Comparison of Sona Nanotech's Debt-to-Equity

For the Diagnostics & Research subindustry, Sona Nanotech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sona Nanotech's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Sona Nanotech Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Sona Nanotech's Debt to Equity Ratio for the fiscal year that ended in Oct. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.395)	/	2.509
	=	0.16

Sona Nanotech's Debt to Equity Ratio for the quarter that ended in Jan. 2025 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.408)	/	1.685
	=	0.24

Sona Nanotech (XCNQ:SONA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Sona Nanotech Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sona Nanotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (XCNQ:SONA) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

SNANF:USA

Address

1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7

Website

https://www.sonanano.com

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

No Headlines